While much of the rules package authored earlier this year by DOH and re-released this month after public feedback, including fees to run a dispensary to possession limits, was largely supported by stakeholders and legislators, the interim rules committee reverted a handful of provisions, including a requirement that doctors certify home-cultivators and a rule adding glaucoma to a list of eligibility conferring debilitating medical conditions.
The rules review committee also kicked back to DOH a requirement that would’ve required marijuana products be entirely packaged for commercial sale when it leaves the grow facility — effectively ending the possibility of bulk shipment. That drew criticism from the cannabis industry, with lobbyist Jeremiah Murphy arguing the ban would cut out the “little guy,” or potential business owners who wanted to grow medical cannabis and ship to a separate facility or business to be packaged and then sold to a retail center.
Sen. Timothy Johns, R-Lead, agreed, noting the rule would fall foul of the “general practice of all commercial enterprise of this nature that you would ship in bulk and then could be packaged at the dispensary.”
Opponents to the revised rules package stood up, from optometrists opposed to DOH’s addition of